Latest Ratings for SIBN
DateFirmActionFromTo Mar 2022Morgan StanleyMaintainsOverweight Jan 2022B of A SecuritiesMaintainsBuy Dec 2021Truist SecuritiesMaintainsBuy
View More Analyst Ratings for...
SI-BONE, Inc. (NASDAQ:SIBN - Get Free Report) insider Anthony J. Recupero sold 3,307 shares of SI-BONE stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of...
This indicator may be signaling that SIBN's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Assenagon Asset Management S.A. grew its holdings in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 92.3% in the fourth quarter, according to the company in its most recent 13F filing with...
This indicator may be signaling SIBN's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
This is a signal that SIBN's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Titan Medical (NASDAQ:TMDIF Get Free Report) and SI-BONE (NASDAQ:SIBN Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two...
SI-BONE, Inc. (NASDAQ:SIBN Get Free Report) hit a new 52-week low during mid-day trading on Friday . The company traded as low as $15.47 and last traded at $15.47, with a volume of 6521...